1,2,4-and 1,3,4-Oxadiazoles as Scaffolds in the Development of Antiparasitic Agents

被引:78
作者
Pitasse-Santos, Paulo [1 ]
Sueth-Santiago, Vitor [2 ]
Lima, Marco E. F. [1 ]
机构
[1] Univ Fed Rural Rio de Janeiro, Dept Quim, BR-465,Km 7, BR-23897000 Seropedica, RJ, Brazil
[2] Inst Fed Educ Ciencia Tecnol & Rio de Janeiro, Rua Jose Augusto Pereira Santos S-N, BR-24425004 Sao Goncalo, RJ, Brazil
关键词
drug design; bioisosterism; heterocyclic drugs; anti-infective drugs; BIOLOGICAL EVALUATION; TRYPANOSOMA-CRUZI; ANTILEISHMANIAL AGENTS; CATALYZED SYNTHESIS; MOLECULAR DOCKING; ANTIFUNGAL AGENTS; IN-VITRO; DERIVATIVES; OXADIAZOLE; HETEROCYCLES;
D O I
10.21577/0103-5053.20170208
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In this review, we present the potential use of the heterocyclic oxadiazole rings in the design and synthesis of new drugs to treat parasitic infections. We intend to compare herein all the four isomeric forms of oxadiazole rings as well as discuss the differences and similarities between them. In addition, we discuss aspects on their reactivity that justify the great importance of both 1,2,4- and 1,3,4-oxadiazoles isomers when compared with their other two isomers. Although some oxadiazole isomers satisfy Huckel's rule, there are differences concerning their aromaticity, which have a great impact on the possible interactions of the oxadiazole ring with biological receptors. The set of works selected from the literature and discussed herein points out the oxadiazole core as an important and versatile scaffold in the development of new chemical entities potentially useful as antiparasitic drugs.
引用
收藏
页码:435 / 456
页数:22
相关论文
共 85 条
  • [1] ANTHELMINTIC ACTIVITY OF 1,2,4-OXADIAZOLES
    AINSWORT.C
    BUTING, WE
    DAVENPOR.J
    CALLENDE.ME
    MCCOWEN, MC
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1967, 10 (02) : 208 - &
  • [2] Alder J., 1864, Transactions of the Zoological Society of London, V5, P113, DOI [10.1111/j.1096-3642.1864.tb00643.x, DOI 10.1111/J.1096-3642.1864.TB00643.X]
  • [3] Expeditious Synthesis, Antimicrobial and Antimalarial Activities of Novel Heterocycles Bearing Imidazole-oxadiazole Based Hybrid Pharmacophores
    Balaji, K.
    Bhatt, P.
    Jha, A.
    [J]. DRUG RESEARCH, 2016, 66 (11) : 587 - 591
  • [4] An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles
    Baumann, Marcus
    Baxendale, Ian R.
    [J]. BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 2013, 9 : 2265 - 2319
  • [5] [1,2,4]-Oxadiazoles: Synthesis and Biological Applications
    Bora, Rajesh O.
    Dar, Bashir
    Pradhan, Vidya
    Farooqui, Mazahar
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2014, 14 (04) : 355 - 369
  • [6] Do structurally similar ligands bind in a similar fashion?
    Bostrom, Jonas
    Hogner, Anders
    Schmitt, Stefan
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (23) : 6716 - 6725
  • [7] Corrosion inhibition performance of 2,5-bis(4-dimethylaminophenyl)-1,3,4-oxadiazole for carbon steel in HCl solution: Gravimetric, electrochemical and XPS studies
    Bouanis, M.
    Tourabi, M.
    Nyassi, A.
    Zarrouk, A.
    Jama, C.
    Bentiss, F.
    [J]. APPLIED SURFACE SCIENCE, 2016, 389 : 952 - 966
  • [8] Ultrasound-promoted synthesis of 3-trichloromethyl-5-alkyl(aryl)-1,2,4-oxadiazoles
    Bretanha, Lizandra C.
    Teixeira, Vinicius E.
    Ritter, Marina
    Siqueira, Geonir M.
    Cunico, Wilson
    Pereira, Claudio M. P.
    Freitag, Rogerio A.
    [J]. ULTRASONICS SONOCHEMISTRY, 2011, 18 (03) : 704 - 707
  • [9] Total Synthesis and Biological Evaluation of Phidianidines A and B Uncovers Unique Pharmacological Profiles at CNS Targets
    Brogan, John T.
    Stoops, Sydney L.
    Lindsley, Craig W.
    [J]. ACS CHEMICAL NEUROSCIENCE, 2012, 3 (09): : 658 - 664
  • [10] Design, synthesis and evaluation of bitopic arylpiperazinephenyl-1,2,4-oxadiazoles as preferential dopamine D3 receptor ligands
    Cao, Yongkai
    Min, Chengchun
    Acharya, Srijan
    Kim, Kyeong-Man
    Cheon, Seung Hoon
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (02) : 191 - 200